Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Portfolio has also been successful in litigation

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

cytoman

Rank: Treasurer [?]

Points: 621 [?]

Votes: 35 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Portfolio has also been successful in litigation

posted on Jul 27, 2010 03:52PM

From the alliacense press release:

More than 75 global, market-leading companies from the US, Europe, Japan, Korea, Taiwan and China have licensed the MMP Portfolio™ technologies, resulting in over $300 million in licensing revenue. The MMP Portfolio has also been successful in litigation, with eight litigants purchasing licenses.

Can someone list the eight?

3 Recommendations